Summary Medical device regulators have tightened guidance on adaptive AI systems, and new clearance throughput has dropped as reviewers work through post-market monitoring requirements. Device makers are extending timelines and revisiting clinical validation plans to avoid costly requalification delays.
Facts on record: 7 observed sources contribute to this signal.